MiRNA and LncRNA as potential biomarkers in triple-negative breast cancer: a review
SR Volovat, C Volovat, I Hordila, DA Hordila… - Frontiers in …, 2020 - frontiersin.org
Noncoding RNAs (ncRNAs) include a diverse range of RNA species, including microRNAs
(miRNAs) and long noncoding RNAs (lncRNAs). MiRNAs, ncRNAs of approximately 19–25 …
(miRNAs) and long noncoding RNAs (lncRNAs). MiRNAs, ncRNAs of approximately 19–25 …
[HTML][HTML] lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment
H Jin, W Du, W Huang, J Yan, Q Tang, Y Chen… - … Therapy-Nucleic Acids, 2021 - cell.com
Breast cancer is a malignant tumor that has a high mortality rate and mostly occurs in
women. Although significant progress has been made in the implementation of personalized …
women. Although significant progress has been made in the implementation of personalized …
Recent treatment progress of triple negative breast cancer
Y Chang-Qing, L Jie, Z Shi-Qi, Z Kun, G Zi-Qian… - Progress in biophysics …, 2020 - Elsevier
Breast cancer (BC) is a serious worldwide disease that threatens women's health.
Particularly, the morbidity of triple-negative breast cancer (TNBC) is higher than that of other …
Particularly, the morbidity of triple-negative breast cancer (TNBC) is higher than that of other …
Roles of miRNA and IncRNA in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is currently the most malignant subtype of breast
cancer without effective targeted therapies, which makes its pathogenesis an important …
cancer without effective targeted therapies, which makes its pathogenesis an important …
Development and validation of a circulating microRNA panel for the early detection of breast cancer
R Zou, SY Loke, YC Tang, HP Too, L Zhou… - British journal of …, 2022 - nature.com
Background Mammography is widely used for breast cancer screening but suffers from a
high false-positive rate. Here, we perform the largest comprehensive, multi-center study to …
high false-positive rate. Here, we perform the largest comprehensive, multi-center study to …
Circular RNA hsa_circRNA_103809 promoted hepatocellular carcinoma development by regulating miR‐377‐3p/FGFR1/ERK axis
W Zhan, X Liao, Z Chen, L Li, T Tian… - Journal of Cellular …, 2020 - Wiley Online Library
In the last decade, circular RNAs (circRNAs) emerge as important regulators in multiple
biological processes. Lately, it is reported hsa_circRNA_103809 could play vital parts in …
biological processes. Lately, it is reported hsa_circRNA_103809 could play vital parts in …
ZEB1 induced‐upregulation of long noncoding RNA ZEB1‐AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the …
N Luo, K Zhang, X Li, Y Hu - Journal of cellular biochemistry, 2020 - Wiley Online Library
Triple‐negative breast cancer (TNBC) is one of the malignant type of breast cancer.
Previous study indicated that long noncoding RNA (lncRNA) ZEB1‐AS1 was associated with …
Previous study indicated that long noncoding RNA (lncRNA) ZEB1‐AS1 was associated with …
Long noncoding RNAs in triple‐negative breast cancer: A new frontier in the regulation of tumorigenesis
In recent years, triple‐negative breast cancer (TNBC) has emerged as the most aggressive
subtype of breast cancer and is usually associated with increased mortality worldwide. The …
subtype of breast cancer and is usually associated with increased mortality worldwide. The …
A novel circular RNA hsa_circRNA_103809/miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC)
X Zhu, J Han, H Lan, Q Lin, Y Wang, X Sun - BMC cancer, 2020 - Springer
Background Cisplatin is the first-line chemotherapeutic drug for non-small cell lung cancer
(NSCLC), and emerging evidences suggests that targeting circular RNAs (circRNAs) is an …
(NSCLC), and emerging evidences suggests that targeting circular RNAs (circRNAs) is an …
MicroRNA-377: A therapeutic and diagnostic tumor marker
Cancer is considered as one of the main causes of human deaths globally. Despite the
recent progresses in therapeutic modalities, there is still a high rate of mortality among …
recent progresses in therapeutic modalities, there is still a high rate of mortality among …